Eye Supplements Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Eye Supplements Market: By Ingredient Type (Lutein and Zeaxanthin, Omega-3 Fatty acids, Coenzyme Q, Flavonoids, Antioxidants Others), By Source (Natural, Synthetic), By Formulation (Tablets, Capsules, Liquids, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Eye supplements market was valued at US$ 1.5 Bn in 2019 and poised to grow at CAGR 6.3%. over 2020 to 2026. The Report gives comprehensive outlook on eye nutrition supplements across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on gives historical, current, and future market sizes (US$ Mn) of product type, dosage form, distribution channel, and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the eye nutrition supplements market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of eye nutrition supplements. Eye supplements market is highly fragmented as many players operating in eye nutrition supplements. Companies are adopting different growth strategies to enhance their sales revenue. Few companies adopted acquisitions, product launches, novel product claims, new distribution channels, collaborating with retail stores, educating ophthalmologists, and social media marketing are some of the key strategies. In 2015, Alliance Pharma plc, acquired MacuVision Europe Limited (MacuVision) for £ 5.5 Mn to add eye care portfolio. As a part of differentiating strategy, Bausch + Lomb (Valeant) product PreserVision Eye Vitamin AREDS Formula Tablets claimed on their product label “Doctor #1 Recommended” to gain confidence from consumers.


Eye Supplements Market

MARKET SUMMARY
-
6.3% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 6.3%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Eye Supplements Market

  • Eye supplements market expanding at 6.3% CAGR over 2021 to 2027 to reach market value of US$ 2.5 Bn by 2027
  • Based on ingredient type, lutein and zeaxanthin accounted for larger market share in 2016 owing to their clinical efficacy in prevention of eye ailments
  • Gummies segment projected to register highest CAGR
  • Supermarkets and Hypermarkets are major distribution channel for eye nutrition supplements
Market Key Players
  • Bausch + Lomb (Valeant) (Canada)
  • Vitabiotics Ltd. (U.K.)
  • Alliance Pharma plc (U.K.)
  • Efamol Ltd (U.K.)
  • Alcon Laboratories (Novartis AG) (Switzerland)
  • Pfizer Inc. (U.S.)
  • EyeScience (U.S.)
Drivers And Restraints

Eye Supplements Market

Eye diseases and disorders is one of the biggest healthcare burden for many countries. Growing incidence and prevalence of eye ailments and increase in aging population are driving the growth of the market. For instance, age-related macular degeneration (AMD) condition mainly affects people with age over 50 and responsible for loss of person’s central vision. As per the estimates of the National Health Service (NHS) UK, it currently affects more than 0.6 Mn people in the UK and predicted to reach 0.7 Mn by 2020. Furthermore, as a preventive measure various government bodies and companies creates awareness programs about eye health and promotes importance of eye nutrition supplements. For instance, in February 2017, Allergan launched See America public awareness campaign to increase awareness and access to eye examinations. The launch of new pharmaceutical drugs and medical devices that can treat various eye ailments such as cataracts, glaucoma, age-related macular degeneration (AMD), genetic diseases, and others are hampering the growth of market. Furthermore, product recalls from companies due to issues with eye nutrition supplements. For instance, in 2010, Bausch + Lomb (Valeant) recalled its PreserVision Eye Vitamin AREDS 2 Formula in the U.S market due to choking sensations reported in people with age over 70.


North-America got significant share

Eye Supplements Market

North America market accounts significant market share in the eye nutrition supplements market owing to increase in consumer awareness about preventive health, easy availability of supplements, and new product launches are responsible for the growth of the North America market. Furthermore, increase in prevalence and incidence of the eye ailments in the U.S. are fueling the growth of the market. In Europe, Russia and United Kingdom are the key markets for eye nutrition supplements. Asia-Pacific region is projected to register highest CAGR over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast.
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Segmentation

Eye Supplements Market


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Eye Supplements Market Introduction
2.1. Global Eye Supplements Market – Taxonomy
2.2. Global Eye Supplements Market –Definitions
2.2.1. By Ingredient Type
2.2.2. By Source
2.2.3. By Formulation
2.2.4. By Distribution Channel
2.2.5. By Region
3. Global Eye Supplements Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Eye Supplements Market Dynamic Factors – Impact Analysis
3.6. Global Eye Supplements Market – Competition Landscape
4. Global Eye Supplements Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Eye Supplements Market, By Ingredient Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Lutein and Zeaxanthin
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Omega-3 Fatty Acids
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Coenzyme Q10
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Flavonoids
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Antioxidants
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Eye Supplements Market Forecast, By Source, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Natural
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Synthetic
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Eye Supplements Market Forecast, By Formulation, 2017 – 2021 and Forecast, 2022 – 2028
7.1. Tablets
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Capsules
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Liquids
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Eye Supplements Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Eye Supplements Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Eye Supplements Market – Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Region, 2022 – 2028
10. North America Eye Supplements Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Ingredient Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Lutein and Zeaxanthin
10.1.2. Omega-3 Fatty acids
10.1.3. Coenzyme Q10
10.1.4. Flavonoids
10.1.5. Antioxidants
10.1.6. Others
10.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Natural
10.2.2. Synthetic
10.3. Formulation Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Tablets
10.3.2. Capsules
10.3.3. Liquids
10.3.4. Others
10.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.4.4. Others
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Eye Supplements Market – Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Country, 2022 – 2028
10.7. North America Eye Supplements Market Dynamics – Trends
11. 1Europe Eye Supplements Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Ingredient Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Lutein and Zeaxanthin
11.1.2. Omega-3 Fatty acids
11.1.3. Coenzyme Q10
11.1.4. Flavonoids
11.1.5. Antioxidants
11.1.6. Others
11.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Natural
11.2.2. Synthetic
11.3. Formulation Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Tablets
11.3.2. Capsules
11.3.3. Liquids
11.3.4. Others
11.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.4.4. Others
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Eye Supplements Market – Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Country, 2022 – 2028
11.7. Europe Eye Supplements Market Dynamics – Trends
12. Asia-Pacific Eye Supplements Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Ingredient Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Lutein and Zeaxanthin
12.1.2. Omega-3 Fatty acids
12.1.3. Coenzyme Q10
12.1.4. Flavonoids
12.1.5. Antioxidants
12.1.6. Others
12.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Natural
12.2.2. Synthetic
12.3. Formulation Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Tablets
12.3.2. Capsules
12.3.3. Liquids
12.3.4. Others
12.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.4.4. Others
12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Eye Supplements Market – Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Country, 2022 – 2028
12.7. Asia-Pacific Eye Supplements Market Dynamics – Trends
13. Latin America Eye Supplements Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Ingredient Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Lutein and Zeaxanthin
13.1.2. Omega-3 Fatty acids
13.1.3. Coenzyme Q10
13.1.4. Flavonoids
13.1.5. Antioxidants
13.1.6. Others
13.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Natural
13.2.2. Synthetic
13.3. Formulation Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Tablets
13.3.2. Capsules
13.3.3. Liquids
13.3.4. Others
13.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.4.4. Others
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Eye Supplements Market – Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Country, 2022 – 2028
13.7. Latin America Eye Supplements Market Dynamics – Trends
14. Middle East and Africa Eye Supplements Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
14.1. Ingredient Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Lutein and Zeaxanthin
14.1.2. Omega-3 Fatty acids
14.1.3. Coenzyme Q10
14.1.4. Flavonoids
14.1.5. Antioxidants
14.1.6. Others
14.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Natural
14.2.2. Synthetic
14.3. Formulation Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Tablets
14.3.2. Capsules
14.3.3. Liquids
14.3.4. Others
14.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.4.4. Others
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Eye Supplements Market – Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Country, 2022 – 2028
14.7. MEA Eye Supplements Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Ingredient Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Vitabiotics Ltd. (U.K.)
15.2.2. Alliance Pharma plc (U.K.)
15.2.3. Efamol Ltd (U.K.)
15.2.4. Alcon Laboratories (Novartis AG) (Switzerland)
15.2.5. Pfizer Inc. (U.S.)
15.2.6. EyeScience (U.S.)
15.2.7. The Nature’s Bounty Co (U.S.)
15.2.8. Amway (U.S.)
15.2.9. Orthomol (Germany)
15.2.10. Biosyntrx Inc. (U.S.)
15.2.11. Bausch + Lomb (Valeant) (Canada)
16. Research Methodology
 17.Key Assumptions and Acronyms

Report

Company Profile

  • Vitabiotics Ltd. (U.K.)
  • Alliance Pharma plc (U.K.)
  • Efamol Ltd (U.K.)
  • Alcon Laboratories (Novartis AG) (Switzerland)
  • Pfizer Inc. (U.S.)
  • EyeScience (U.S.)
  • The Nature’s Bounty Co (U.S.)
  • Amway (U.S.)
  • Orthomol (Germany)
  • Biosyntrx Inc. (U.S.)
  • Bausch + Lomb (Valeant) (Canada)

Description

Eye supplements market was valued at US$ 1.5 Bn in 2019 and poised to grow at CAGR 6.3%. over 2020 to 2026. The Report gives comprehensive outlook on eye nutrition supplements across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on gives historical, current, and future market sizes (US$ Mn) of product type, dosage form, distribution channel, and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the eye nutrition supplements market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of eye nutrition supplements. Eye supplements market is highly fragmented as many players operating in eye nutrition supplements. Companies are adopting different growth strategies to enhance their sales revenue. Few companies adopted acquisitions, product launches, novel product claims, new distribution channels, collaborating with retail stores, educating ophthalmologists, and social media marketing are some of the key strategies. In 2015, Alliance Pharma plc, acquired MacuVision Europe Limited (MacuVision) for £ 5.5 Mn to add eye care portfolio. As a part of differentiating strategy, Bausch + Lomb (Valeant) product PreserVision Eye Vitamin AREDS Formula Tablets claimed on their product label “Doctor #1 Recommended” to gain confidence from consumers.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX